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ABSTRACT: In this work, we proposed the method to maintain
the desired level of drug’s solubility within the polymer matrix by
adjusting conditions to uphold the same molecular dynamics of the
system (e.g., temperature for set elevated pressure or vice versa).
Namely, we observed, that recrystallization of the drug from the
supersaturated drug−polymer system, initiated for the same
structural relaxation time of the sample (τα‑1) ceases when certain,
different than the initial, molecular mobility of the systems is
reached (τα‑2)regardless of a given combination of temperature
and pressure conditions. Based on the presented results, one can
conclude that the molecular dynamics seem to control the process
of recrystallization of the excess amount of solute from the
supersaturated solution (e.g., small molecules dissolved within the polymer). Therefore, it appears that the elevated pressure
compensates the effect of solubility enhancement caused by the elevated temperature. Such information not only is of fundamental
relevance in science but also, from a much broader perspective, could be potentially very useful considering extrusion-based
manufacturing methods.
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■ INTRODUCTION
The solubility of small molecules (SMs) within the polymer
matrixes has been of great scientific interest in the past
decades.1−6 The special case of this phenomenon considering
drugs as SMs dissolved within the polymers has been
extensively explored because of its importance to the
pharmaceutical industry.5,7−16 A great number of the experi-
ments, performed under isobaric (ambient) conditions,
allowed to explore the subject of drug−polymer solubil-
ity.3,5,10,11,15,17−19 As a result of those efforts, our knowledge
about this process increased. Namely, among many factors that
affect the solubility of SMs within the polymer matrix, the
temperature is assumed to be the most important one,
governing this phenomenon.1,20−24 Furthermore, performed
studies helped to develop and improve theoretical models that
allow calculating the discussed solubility. Therefore, to this
day, determination of the solubility of SMs within the polymer
matrix can be predicted with the use of one of the following:
(i) Flory−Huggins theory;1,20−22,25 (ii) Hansen’s solubility
parameter;4,12,23 and (iii) perturbed-chain statistical associating
fluid theory.13,14,24 Nevertheless, it should be emphasized that
when we compare the number of reports addressing this issue
at ambient pressure conditions with those performed at
elevated pressure, the significant disproportion will be found.
In a recent study, antiandrogen drugflutamide (FL)was
dissolved within the copolymer matrixKollidon VA64
(PVP/VA)and its solubility was examined at various sets
of elevated temperatures and pressures.26 On the one hand, the
generally accepted dependence between temperature and
solubility limit [solubility (S) is proportional to temperature:
S ∼ T] was observed regardless of applied pressure (under
isobar conditions). On the other hand, the result of the
increasing pressure (at constant temperature) was the
reduction in the amount of FL that could be successfully
dissolved within the polymer. Therefore, S ∼ T and at the
same time, by following the cited report, solubility is inversely
proportional to the applied pressure: S ∼ 1/p. This is crucial
information considering extrusion-based manufacturing meth-
ods (e.g., hot melt extrusion) because of the fact that pressures
generated within an extruder can reach very high values (up to
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10,000 psi or 70 MPa),27 especially, because it has been shown
in our recent study that pressure in that range may cause the
precipitation/crystallization of the original dissolved drug. By
utilizing Broadband Dielectric Spectroscopy (BDS) to
determine the solubility limit of the SMs (e.g., drugs) dissolved
within the polymer matrixes, one can additionally monitor the
Figure 1. Data from ref 26. Upper panels present relaxation map of binary mixtures of FL with 55, 41, 27, and 13 wt % of PVP/VA at 20 MPa (a)
and 50 MPa (b). Temperature dependence of τα in the supercooled liquid has been described by VFT equations (gray and red solid lines). Fits
transferred horizontally are marked as brown and green solid lines. Left bottom and middle panels show relaxation maps of the FL + 13% PVP/VA
mixture before and after the recrystallization under certain temperature and pressure conditions. (c) τα(T) registered for the sample after
isothermal crystallization at 0.1 MPA and at 343, 353, and 363 K (orange, brown, and dark green circles, respectively). (e) τα(T) registered for the
sample after isothermal crystallization at 363 K and at 0.1, 20, and 50 MPa (dark green circles, diamonds, and pentagons, respectively). τα(T) in the
supercooled liquid has been described by VFT equations (red solid lines). Red dashed line is the horizontal transfer of the VFT fit of the nearest
fully amorphous concentration. Right panels present experimentally determined concentrations dependencies of the Tg of the FL-PVP/VA mixtures
at 0.1 (d,f), 20 (f), and 50 MPa (f). Brown, and dark green points correspond to the concentrations obtained after the recrystallization under
isothermal  353, and 363 K, respectively  conditions. Pentagons, diamonds, and circles correspond to the concentration at certain pressure 
50, 20, and 0.1 MPa, respectively  conditions.
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changes occurring in the molecular dynamics of the examined
system during the whole process.8,16,26,28,29 Furthermore, the
value of the structural relaxation time (τα) of the measured
system, which reflects its molecular mobility,30−32 can be
determined during dielectric measurements. As it was proven
in the case of a viscous liquid, the effect of the increasing
pressure on τα is similar to the effect of the decreasing
temperature.33,34 Therefore, one can directly link it to
temperature (as inversely proportional to) and pressure (as
proportional to) in the following fashion: τα ∼ 1/T and τα ∼
p.35−38
The central idea behind the present work is to provide an
easy and simple way to determine the conditions needed to
maintain a given level of the solubility under various pressures
(temperature adjustment to prevailing pressure conditions).
This is based on two parameters τα and S. Given their inverse
dependence on temperature and pressure: S ∼ T/p and τα ∼
p/T,33−38 their mutual relation can be considered. If that is the
case, then solubility should be inversely proportional to the τα
of the system (S ∼ 1/τα) at the beginning of crystallization.
This would mean that, regardless of the chosen temperature or
pressure, while maintaining the isochronal conditions, one
should always obtain the same limiting concentration. In order
to facilitate the investigation, we decided to perform the
necessary analysis on the system well-characterized under both
ambient and elevated pressure conditionsFL-PVP/VA.16,26
Furthermore, in order to determine the solubility limit of the
system under compression as well as to determine its τα, we
utilized BDS.
■ EXPERIMENTAL SECTION
Materials. FL drug of molecular mass MW = 276.21 g
mol−1 and purity ≥99% was purchased from Sigma-Aldrich
and used without further purification. Poly vinylpyrrolidone
vinylacetate  Kollidon VA64 (PVP/VA) of molecular mass
MW = 45,000−47,000 g mol−1 was purchased from BASF SE
(Ludwigshafen, Germany). The sample was received as a white
powder and used without further purification.
The glass-transition temperature of the bulk polymer
determined from the differential scanning calorimetry (DSC)
measurements is 376 K (recorded on a second heating run,
after cooling from 420 to 265 K with a cooling rate of 20 K/
min). From the dielectric relaxation studies, we get Tg = 376 K
(defined as a temperature at which τα = 100 s, data not
shown).
The glass-transition temperature of the drug determined
from the DSC measurements is 274 K (recorded on a second
heating run, after cooling from 410 to 253 K with a cooling
rate of 20 K/min). From the dielectric relaxation studies, we
get Tg = 271 K (defined as a temperature at which τα = 100
s).16
Preparation of Binary Systems. To acquire homoge-
neous samples, we mixed the compound with the polymer at
appropriate ratios in a mortar. Sample preparation for the BDS
and high-pressure BDS measurements involved melting at T =
410 K, followed by vitrification on a previously chilled copper
plate. All measurements were performed immediately after the
preparation of the amorphous systems to avoid recrystalliza-
tion.
Broadband Dielectric Spectroscopy. The dielectric
measurements of FL-based ASDs were carried out using a
Novo-Control GMBH Alpha dielectric spectrometer (Mon-
tabaur, Germany) in the frequency range from 10−1 to 106 Hz
at given temperatures with a heating rate ∼ 0.5 K/min. The
temperature was controlled by a Quatro temperature controller
with temperature stability better than 0.1 K. Dielectric studies
of FL and its binary systems were performed immediately after
its vitrification by fast cooling of the melt in a parallel-plate cell
made of stainless steel (diameter 15 mm and a 0.1 mm gap
with quartz spacers).
For the high-pressure BDS measurements, we additionally
employed a high-pressure Unipress U111 setup (Warszawa,
Poland). Herein, the sample was measured in a similar, made
of stainless steel, parallel-plate cell (diameter of 15 mm and a
0.1 mm gap with Teflon spacers). It was sealed and mounted
by a Teflon tape to separate it from the silicon liquid. The
temperature was adjusted with a precision of 0.1 K by the
Julabo heating circulator (Seelbach, Germany).
■ RESULTS AND DISCUSSION
In order to test the validity of the proposed idea, we performed
the series of dielectric measurements under various temper-
ature and pressure conditions and additionally analyzed
recently published data of FL-PVP/VA.26 The initial part of
this study will focus on the analysis of the already published
data, especially on the temperature dependencies of the
relaxation times of the FL-PVP/VA systems under various
pressure conditions. The detailed analysis of obtaining such
dependency is described along the experimental part later on.
In recalled paper, we determined the solubility limit of FL
within the polymer matrix under both ambient and elevated
pressure conditions. Figure 1 shows the temperature depend-
ence of the α-relaxation time [τα(T)] registered for the FL +
13 wt % of PVP/VA sample both before (gray circles) and
after isothermal crystallization at 0.1, 20, and 50 MPa and at
353 and 363 K (brown and green symbols, respectively).
Temperature evolution of the structural relaxation time  in
supercooled liquid region  usually shows non-Arrhenius-like
behavior. Hence, in order to parameterize it, we used the














where τ∞, B, and T0 are the fitting parameters. It has to be
pointed out that in the case of some of the measurements,
performed at elevated pressure (e.g., FL + 13 wt % of PVP/VA
system after recrystallization at at 363 K and 20 MPa), the
number of the experimentally determined τα after recrystalliza-
tion is not sufficient to parameterize it well with the VFT
equation (see brown diamond in Figure 1a). However, because
of the close proximity of different, well-parameterized
concentrations: FL + 41 wt % of PVP/VA (VFT fit presented
as dark gray solid line in Figure 1a,b), we decided to transfer
horizontally its VFT fit to match determined τα(T). Validation
of the proposed approach can be seen in case of the
recrystallization of the FL + 13 wt % of PVP/VA at 363 K
and 20 MPa  Figure 1a  the horizontally transferred fit of
the fully amorphous FL + 41 wt % of PVP/VA system
registered at 20 MPa (green line) is in very good agreement
with the VFT fit of the experimental points of the system
registered after recrystallization at 363 K and 20 MPa (red
solid line). Glass-transition temperature determined in both
cases is equal to 318 K.
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From the extrapolation of the VFT fit up to the
temperatures of the isothermal crystallization, we were able
to determine the initial τα of the system (see Figure 1c,e). It
has to be pointed out that its experimental determination
would be impossible because of the sample’s vast tendency
toward recrystallization.26 As can be seen, the relaxation time
of the system becomes shorter as the temperature increases,
which is a well-known phenomenon. However, focusing on the
solubility limits determined in ref 26, one can observe that
besides the fact that with increasing temperature (at constant
pressure) the solubility of FL in the polymer matrix increases
(which is consistent with data reported in the case of different
pharmaceuticals5,10,11,15,17−19,42,43), the conditions that corre-
spond to the longest relaxation time at the beginning of the
recrystallization result in the lowest amount of the drug that
can be successfully dissolved within the polymer (see Figure
1d). This would also not be a surprising phenomenon
considering mutual dependence between the temperature
and relaxation time observed in Figure 1c.
At this point, it should be mentioned that τα does not
depend solely on the temperature but can be affected by the
pressure as well.33,34 Therefore, we performed additional
analysis on the recalled results obtained under elevated
pressure conditions (see Figure 1e). As can be seen, the
relaxation time is getting longer as the pressure elevates, which
is an effect similar to the lowering of the temperature and has
already been observed.33,34 Accordingly, the highest amount of
the FL, which can be effectively dissolved within the Kollidon
VA64 matrix, is related to the conditions that correspond with
the shortest relaxation time. Based on these examples, we
propose the idea that the mentioned solubility is inversely
proportional to the relaxation time of the system.
Throughout aforementioned steps we confirmed the
following facts about the FL-PVP/VA systems: (i) τα of this
system is proportional to the pressure and inversely propor-
tional to the temperature (τα ∼ p/T); (ii) solubility of the FL
within the PVP/VA matrix is proportional to the temperature
and inversely proportional to the pressure (S ∼ T/p).
Considering proposed idea, one should obtain the same
limiting concentration while maintaining the same molecular
dynamics of the system, regardless of the chosen temperature
or pressure. Therefore, in the following part of this study, we
focus on the conducted measurements. We performed
crystallization studies at which the sample was stored under
isochronal conditions (at various sets of temperature and
pressure conditions that were chosen with regard to the fully
amorphous sample). We have chosen τα = 0.13 μs, τα = 0.52
μs, and τα = 2.7 μs for our measurements because of the fact
that the recrystallization under these conditions should
progress relatively fast.
The representative dielectric loss spectra of the FL+ 10 wt %
PVP/VA mixture which were obtained during heating, above
sample’s glass-transition temperature (Tg), are shown in Figure
2a. The presented spectra exhibit one well-resolved loss peak
corresponding to the structuralαrelaxation. The intensity
of this peak slightly decreases as it moves toward higher
frequencies with the increasing temperature up to 307 K.
Above this temperature (i.e., at 309 K), one can observe a
substantial decrease of the dielectric strength (Δε), which
corresponds to the considerable drop in the intensity of the
structural relaxation peak. By acknowledging the fact that Δε is
proportional to the number of units involved in structural
relaxation, the discussed rapid drop would indicate the onset of
the sample’s recrystallization.44,45
To obtain the values of τα at various temperatures and
consequently determine the temperature dependencies of the
α-relaxation times for all examined systems, dielectric spectra
collected above the sample’s glass-transition temperature (Tg)
were fitted using the HN function46
i i
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where ε∞ is high-frequency limit permittivity, ε0 is the
permittivity of vacuum, Δε is dielectric strength, ω is equal
to 2πf, τHN is the HN relaxation time, a and b are the
parameters that represent symmetric and asymmetric broad-
ening of relaxation peak, σdc is the dc conductivity, and ε0 is the
dielectric permittivity of the vacuum (the example of the HN
fitting is presented in Figure 2a as the shaded area). Using the
Figure 2. Data presented in this figure were obtained at ambient pressure conditions . (a) Dielectric spectra obtained for the fully amorphous
sample as well as the sample during additional measurements performed after crystallization at 347 K, green and brown solid lines, respectively.
Green and yellow shaded areas correspond to the fit acquired by the Havriliak−Negami (HN) function to the spectrum of fully amorphous and
partially recrystallized sample presented as the green and brown circles, respectively. (b) τα(T) registered for the fully amorphous as well as the FL
+ 10 wt % PVP/VA sample after isothermal crystallization at 347 K. Temperature dependence of τα in the supercooled liquid state has been
described by VFT equations (red solid lines). (c) Dielectric spectra obtained during the isothermal crystallizations registered at 347 K. t0 indicates
the first recorded spectrum at the set temperature, and it does not correspond to the beginning of the crystallization. The light gray dotted spectrum
was not obtained during any measurement  it is presented to help visualize set relaxation time.
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Figure 3. (a) τα(T) registered for the fully amorphous FL + 10 wt % PVP/VA sample (blue pentagons, green diamonds, and dark green circles for
50, 20, and 0.1 MPa, respectively) as well as the sample after isothermal crystallization at (i) 363 K and 50 MPa; (ii) 353 K and 20 MPa; and (iii)
347 K and 0.1 MPa (blue pentagons, turquoise diamonds, and dark green circles, respectively). τα(T) in the supercooled liquid has been described
by VFT equations (red solid lines). Red dashed line is the horizontal transfer of the VFT fit of the nearest fully amorphous concentration (see
Figure 1a,b). (b) Dielectric spectra obtained after the isothermal and isobar crystallization under given conditions. (c) Experimentally determined
concentration dependencies of the Tg of the FL-PVP/VA mixtures at 0.1, 20, and 50 MPa (gray circles, diamonds, and pentagons, respectively).
Light green triangles correspond to the concentrations obtained after the recrystallization under isochronal  τα = 0.13 μs  conditions.
Figure 4. (a) τα(T) registered for the fully amorphous FL + 10 wt % PVP/VA sample (blue pentagons, green diamonds, and dark green circles for
50, 20, and 0.1 MPa, respectively) as well as the sample after isothermal crystallization at (i) 353 K and 50 MPa; (ii) 343 K and 20 MPa; and (iii)
336 K and 0.1 MPa (blue pentagons, turquoise diamonds, and dark green circles, respectively). τα(T) in the supercooled liquid has been described
by VFT equations (red solid lines). Red dashed line is the horizontal transfer of the VFT fit of the nearest fully amorphous concentration (see
Figure 1a,b). (b) Dielectric spectra obtained after the isothermal and isobar crystallization under given conditions. (c) Experimentally determined
concentrations dependencies of the Tg of the FL-PVP/VA mixtures at 0.1, 20, and 50 MPa (gray circles, diamonds, and pentagons, respectively).
Wine triangles correspond to the concentrations obtained after the recrystallization under isochronal  τα = 0.52 μs  conditions.
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fitting parameters determined above, the values of τα (and τα′
for the samples after recrystallization) were calculated by








































Relaxation times obtained from the above described fitting
procedure are presented in Figures 2b, 3a, 4a, and 5a. As can
be seen, the FL + 10 wt % PVP/VA system begins to
recrystallize at relatively low temperatures (under these
conditions, the relaxation time of the sample is far from the
desired value  see Figures 2b, 3a, 4a and 5a). Therefore, in
order to determine the temperature that corresponds to the
chosen τα, we decided to use the VFT equation. From the
extrapolation of the VFT fit up to the selected relaxation time
(e.g., τα = 0.13 μs), we were able to determine the temperature
of the system (see the brown star in Figure 2b). As can be seen
under ambient pressure conditions, the FL + 10 wt % PVP/VA
sample needs to be heated up to the 347 K in order to have the
relaxation time equal to τα = 0.13 μs. This procedure was
repeated for samples under each chosen pressure condition
(i.e., 0.1, 20, and 50 MPa). Once it was done, we were able to
perform isothermal crystallization studies under given con-
ditions in order to determine the solubility limit of the drug
within the polymer matrix. Figure 2c presents the representa-
tive example of performed recrystallization studies. The
presented dielectric spectra show crystallization at 0.1 MPa
and 347 K, t0 indicates the first recorded spectrum at set
temperature, and it does not correspond to the beginning of
the crystallization because of the sample’s tendency toward
recrystallization. The light gray dotted spectrum is presented
only as a visual aid and was not obtained during any
measurement. When the recrystallization of the excess amount
of the SM (FL) from the supersaturated system ceased, one
well-resolved loss peakα′-processwas still visible (as in
previously reported cases8,16,26,28,29), see Figure 2c.
Next, in order to exclude the possibility of correlating this
additional process to either segmental or secondary relaxation
originating from residual amorphous polymer, remaining after
the recrystallization of the whole amount of the drug from the
mixture, we followed the procedure proposed in ref 16.
In order to obtain relaxation times in a wide temperature
range needed to determine the glass-transition temperature
related to the α′-process [Tg = T(τα′ = 100 s)], we cooled
down the sample  when no further changes in molecular
dynamic of the system were observed (no changes for approx.
15 h, see Figure 2c), during/after crystallization  and then
measured it again during heating. As can be observed in Figure
2a (brown lines), during this measurement, the dielectric
spectra of the examined sample have been registered up to the
temperature of the performed isothermal crystallization (e.g.,
347 K). Dielectric spectra obtained throughout this procedure,
just as the spectra of the fully amorphous sample, were then
fitted using the HN fitting function (see Figure 2a).
Determination of the origin of this additional process was
possible, once the temperature dependence of the α′-relaxation
times [τα′(T)] of the partially recrystallized sample was
obtained. Because of the nonlinear behavior of τα′(T) and
the fact that it follows the VFT equation (see brown circles in
Figure 2b), one can easily conclude that the α′-process is the
primary relaxation process of different than initial concen-
Figure 5. (a) τα(T) registered for the fully amorphous FL + 10 wt % PVP/VA sample (blue pentagons, green diamonds, and dark green circles for
50, 20, and 0.1 MPa, respectively) as well as this sample after isothermal crystallization at (i) 343 K and 50 MPa; (ii) 334 K and 20 MPa; and (iii)
327 K and 0.1 MPa (blue pentagons, turquoise diamonds, and dark green circles, respectively). τα(T) in the supercooled liquid has been described
by VFT equations (red solid lines). Red dashed line is the horizontal transfer of the VFT fit of the nearest fully amorphous concentration (see
Figure 1a,b). (b) Dielectric spectra obtained after the isothermal and isobar crystallization under given conditions. (c) Experimentally determined
concentrations dependencies of the Tg of the FL-PVP/VA mixtures at 0.1, 20, and 50 MPa (gray circles, diamonds, and pentagons, respectively).
Dark gray hexagons correspond to the concentrations obtained after the recrystallization under isochronal  τα = 2.7 μs  conditions.
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tration of the drug in the FL-PVP/VA system. We determined
its Tg value by extrapolation of its VFT fit to 100 s. Thus, the
saturated FL-PVP/VA system established under 347 K and 0.1
MPa conditions is characterized by a glass-transition temper-
ature equal to 314 K (see Figure 2b). Next, by following this
procedure in the case of the studies performed at elevated
pressure, we determined the Tg of the saturated systems.
Similarly, as in the case of the measurements, analyzed at the
beginning of this work, the number of the experimentally
determined τα after recrystallization at elevated pressure is not
sufficient to parameterize it well with the VFT equation. This
can be explained by the increased dc conductivity contribution
during BDS measurements at elevated pressure. Therefore, we
decided to transfer horizontally the VFT fit of the FL + 41 wt
% PVP/VA system to match determined τα(T) (red dashed
line in Figure 3a, 4a and 5a).
Figure 3a presents the τα(T)s registered for the fully
amorphous FL + 10 wt % of PVP/VA (at 0.1, 20, and 50 MPa)
samples as well as these samples after crystallization under
isochronal conditions (τα = 0.13 μs): (i) 363 K and 50 MPa;
(ii) 353 K and 20 MPa; (iii) 347 K and 0.1 MPa (blue
pentagons, turquoise diamonds, and dark green circles,
respectively). Dielectric spectra obtained when the recrystal-
lization process ceased exhibit one extraordinary feature, and
despite different temperature and pressure conditions, they all
had been characterized by the same relaxation time 
determined based on the HN fit  τα = 1.27 ms (see Figure
3b). It is interesting that the recrystallization carried out under
the conditions that correspond to τα‑1 ceases at certain 
different than initial  τα‑2. By applying the procedure
discussed in this work, we determined the Tgs of the saturated
systems. By comparing the obtained values to the previously
reported Tg to concentrations dependencies of the FL-PVP/
VA mixtures at 0.1,16 20, and 50 MPa26 we were able to
identify the concentration of the tested system. As can be seen
in Figure 3c, the concentrations obtained by the recrystalliza-
tion under conditions that correspond with τα = 0.13 μs are
equal to 57, 58, and 59 wt % at 50, 20, and 0.1 MPa,
respectively. It has to be pointed out that small differences
between determined concentrations might be due to the, for
example, extrapolation of the VFT fits and/or small number of
the experimental data after the recrystallization of the sample
(because of the increased dc conductivity contribution during
BDS measurements at elevated pressure).
To confirm the validity of our assumption that τα is the key
to maintain the desired solubility limit of a SM within the
polymer matrix at elevated pressure, we conduct additional
measurements for different initial τα. Namely, we performed
recrystallization measurements under isochronal conditions (τα
= 0.52 and 2.7 μs): (i) 353 and 343 K at 50 MPa; (ii) 343 and
334 K at 20 MPa; (iii) 336 and 327 K at 0.1 MPa (Figures 4a
and 5a: blue pentagons, turquoise diamonds, and dark green
circles, respectively).
Analogously as in previously chosen τα when the
recrystallization ceased, dielectric spectra collected under
various sets of temperature and pressure conditions have
been characterized by the exact same relaxation time: τα = 13
ms (see Figure 4b) and τα = 0.3 s (see Figure 5b). Moreover,
as can be seen in Figures 4c and 5c, concentrations obtained by
the recrystallization of the excess amount of the drug under
isochronal conditions are equal to 56, 57, and 58 wt % at 50,
20, and 0.1 MPa, respectively, while starting at τα = 0.52 μs and
54, 55, and 56 wt % at 50, 20, and 0.1 MPa, respectively, while
starting at (τα = 2.7 μs). Once again small deviations between
determined concentrations are present; the explanation of
which has already been given. However, one can observe that
there is a constant difference between the solubility limit
obtained while starting from τα = 2.7 μs, 0.52 μs or 0.13 μs. It
has to be pointed out that in all presented cases of chosen τα
(as a starting point for the recrystallization) systems reach a
defined solubility, based on their initial relaxation time.
Comparing the solubility limit values obtained during the
recrystallization at constant pressure, constant temperature,
and constant relaxation time, one can notice some significant
Figure 6. Experimentally determined concentrations dependencies of the Tg of the FL-PVP/VA mixtures at 0.1, 20, and 50 MPa (gray circles,
diamonds, and pentagons, respectively). Green and orange stars correspond to the Tg value of the concentrations obtained after isothermal
recrystallizations at 363 and 343 K, respectively, at 0.1, 20, and 50 MPa. Wine and light green shadowed area correspond to the concentrations
obtained after the recrystallization under isochronal  τα = 0.52 μs and 0.13 μs  conditions.
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differences (see Figure 6). Namely, maintaining the constant
pressure (either for 0.1 MPa or 50 MPa), while altering the
temperature, we obtained the generally accepted dependence
between temperature and solubility limits  the higher the
temperature, the larger amount of the SMs (in our case FL)
can be successfully dissolved within the polymer ma-
trix5,10,11,15,17−24 (e.g., 59 wt % of FL at 343 K and 64 wt %
of FL at 363 K for 0.1 MPa). On the other hand,
recrystallization conducted at a constant temperature (either
343 or 363 Korange and green stars, respectively, in Figure
6), while applying different pressures, results in the following:
with increasing pressure, the solubility of the FL within the
polymer matrix is decreasing (e.g., 64 wt % of FL at 0.1 MPa
and 57 wt % of FL at 50 MPa for 363 K)  effect similar to
decreasing temperature at constant pressure. However,
measurements carried out at the same relaxation time (either
for τα = 2.7 μs or τα = 0.13 μs), regardless of chosen set of
temperature and pressure conditions, results in the same
concentrationthe same solubility limit (e.g., approx. 55 wt %
of FL for τα = 2.7 μs and 58 wt % of FL for τα = 0.13 μs),
which confirms the initial assumption that the solubility of the
SMs (e.g., FL) within the polymer matrix is inversely
proportional to the τα of their system (S ∼ 1/τα).
It should be pointed out that our understanding of the role
of the isochronal conditions in the solubility limit studies is still
limited and thus the role of many factors (e.g., drug−polymer
interactions) is yet to be understood. The mentioned
interactions have been known to affect both the thermody-
namics and kinetics of the precipitation.47−49 Although in
recent study Prasad et al. showed (on the example of
indomethacin drug) that despite the fact that both used
polymers (Eudragit E100 and PVP K90) interfere with the
kinetics of precipitation via drug−polymer interactions no
significant change in solubility was observed with any of the
added polymers,50 one has to acknowledge that drug−polymer
interactions might either inhibit or induce precipitation
(crystal growth or nucleation) in a manner that is difficult to
predict, which in turn could affect the extent and duration of
supersaturation.51,52 Furthermore, the complexity of this issue
increases when one considers the additional factor  elevated
pressure. The densification of the molecular packing of the
system is a direct result of the applied high pressure and can
lead to the improvement of drug−polymer interactions53 or
vice versa the weakening of hydrogen bonding between drug
and polymer.54
Nevertheless, we strongly believe that this approach along
with the dielectric measurement might become an irreplace-
able tool in predicting the limiting polymer concentration for
the extrusion-based manufacturing purposes. Even though one
might conclude, based on the presented results, that there is a
potential risk, that a change in the solubility limit caused by the
elevated pressure might lead to recrystallization of the excess
amount of the drug during the extrusion process, the presented
idea has not yet been tested during production conditions.
Therefore, we strongly encourage further exploration of this
kind of behavior.
■ CONCLUSIONS
To summarize, the presented experimental results confirm that
regardless of the chosen temperature or pressure, while
sustaining the same initial relaxation time, one would maintain
a desired level of solubility. Furthermore, it seems that the
elevated pressure compensates the effect of solubility enhance-
ment caused by the elevated temperature. Such information is
not only of fundamental relevance in science but also, from a
much broader perspective, could be potentially very useful
considering extrusion-based manufacturing methods. However,
it is but a first step toward the validation of the proposed idea:
mutual dependence between the solubility of all SMs within
the polymers and τα of their systems.
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